Kaufman, J. L., Gasparetto, C., Schjesvold, F. H., Moreau, P., Touzeau, C., Facon, T., . . . Kumar, S. (2021). Targeting BCL‐2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma. Am J Hematol.
استشهاد بنمط شيكاغوKaufman, Jonathan L., et al. "Targeting BCL‐2 With Venetoclax and Dexamethasone in Patients With Relapsed/refractory T(11;14) Multiple Myeloma." Am J Hematol 2021.
MLA استشهادKaufman, Jonathan L., et al. "Targeting BCL‐2 With Venetoclax and Dexamethasone in Patients With Relapsed/refractory T(11;14) Multiple Myeloma." Am J Hematol 2021.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.